Physician profile
Henry W Smith
NPI 1760582951
$3,451.54
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $799 · 2020: $279 · 2021: $382 · 2022: $846 · 2023: $1,049 · 2024: $96.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,145.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $411.07 | 2019-2023 | Repatha |
| Abbott Laboratories | $321.02 | 2019-2024 | Diamondback Coronary |
| Penumbra, INC. | $300.47 | 2019-2022 | |
| Abiomed | $299.49 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $252.60 | 2019-2023 | |
| Medtronic, INC. | $211.93 | 2021-2023 | Onyx Frontier |
| Irhythm Technologies, INC. | $184.62 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Janssen Pharmaceuticals, INC | $152.63 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $150.61 | 2019-2023 | Jardiance |
| Zoll Circulation INC | $146.56 | 2023 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $139.41 | 2019-2021 | |
| Pfizer INC. | $117.90 | 2019-2023 | |
| Shockwave Medical, INC | $104.11 | 2021 | |
| Sanofi-Aventis U.S. LLC | $101.27 | 2019-2023 | |
| Intuitive Surgical, INC. | $86.60 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $62.62 | 2019-2023 | Kengreal |
| E.R. Squibb & Sons, L.L.C. | $51.64 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.28 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $37.27 | 2020-2022 | |
| Philips North America LLC | $36.07 | 2022 | |
| Daiichi Sankyo INC. | $34.36 | 2023 | Injectafer |
| Boston Scientific Corporation | $31.61 | 2021-2023 | Ekosonic |
| Cardiovascular Systems INC. | $28.97 | 2019-2021 | |
| Amarin Pharma, INC. | $28.62 | 2019-2022 | |
| Esperion Therapeutics, INC. | $27.31 | 2021 | |
| Portola Pharmaceuticals, LLC | $23.35 | 2019 | |
| Novo Nordisk INC | $20.34 | 2021 | |
| Alnylam Pharmaceuticals INC. | $19.98 | 2023 | Onpattro |
| Teleflex LLC | $14.09 | 2022 | |
| Merck Sharp & Dohme LLC | $13.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.